Eiger BioPharmaceuticals
(NASDAQ) EIGR
Eiger BioPharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$15.77M
Net Income (TTM)
$74.96M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
EIGR News
![Are_Ultra-High_Drug_Prices_Sustainable[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F619307%2Fare_ultra-high_drug_prices_sustainable1.jpg&w=3840&op=resize)
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Eiger BioPharmaceuticals
EIGR Financials
Key Financial Metrics (TTM)
Gross Margin
95%
Operating Margin
-5%
Net Income Margin
-5%
Return on Equity
-4%
Return on Capital
5%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$15.75M
Operating Income
$71.79M
EBITDA
$68.74M
Operating Cash Flow
$74.55M
Capital Expenditure
$234.00K
Free Cash Flow
$74.78M
Cash & ST Invst.
$25.44M
Total Debt
$41.20M
Eiger BioPharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$3.80M
+41.1%
Gross Profit
$3.70M
+57.5%
Gross Margin
97.34%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
56
N/A
Net Income
$13.45M
+46.5%
EBITDA
$11.85M
+51.2%
Quarterly Fundamentals
Net Cash
$15.76M
-126.8%
Accounts Receivable
$1.68M
-3.8%
Inventory
$1.56M
-45.5%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$41.20M
+8291.6%
Return on Assets
-1.93%
N/A
Return on Invested Capital
4.97%
N/A
Free Cash Flow
$13.96M
+37.9%
Operating Cash Flow
$13.95M
+37.3%